Fig. 3From: Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repairOverall survival after endocrine therapy by p-P38 status; Activation of P38 predicts better long-term outcome in patients treated with up to 5 years of adjuvant endocrine therapyBack to article page